Skip to main content

Table 1 Lung function and clinical characteristics of patients transitioned from HTS to HTS_HMW-HA. Lung function values are expressed as % predicted

From: Effects of inhaled high-molecular weight hyaluronan in inflammatory airway disease

Patient

FEV1/FEV

P. aerug.

 

pre

post

gender

age

pre

post

inh Abx

AZT

BD

inh CS

dorn α

1

104

103

m

9

+

-

TOBI

+

+

+

+

2

101

104

m

19

-

-

colistin

+

+

+

-

3

95

85

f

13

-

-

TOBI

+

-

-

-

4

96

94

m

19

+

+

TOBI, colistin

+

+

+

-

5

113

113

m

18

-

-

-

-

+

-

-

6

102

104

m

8

-

-

-

-

-

-

-

7

87

102

m

16

+

+

TOBI

-

-

-

+

8

69

76

m

23

+

+

TOBI

-

-

-

+

9

104

104

m

23

+

+

TOBI, aztreonam

+

-

-

+

10

97

97

m

12

-

-

-

-

+

+

+

11

97

105

m

14

-

-

colistin

+

-

-

-

12

97

95

f

14

-

-

colistin, aztreonam

+

+

+

+

13

83

80

m

15

-

-

-

-

+

+

-

avg

95.8

97.1

 

15.6

       

SD

11.0

10.9

 

4.7

       

p

0.57

         
  1. Abbreviations: avg average value, SD standard deviation, TOBI inhaled tobramycin, Abx antibiotics, AZT azithromycin, BD chronic bronchodilator treatment, CS corticosteroids, p significance value in Wilcoxon matched-pairs, signed-rank test